Heartbeam Inc(BEAT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BEAT Heartbeam Inc

Not Yet Opened 11-25 16:00:00 EST

2.83

+0.04

+1.43%

盘后2.83

+0.000.00%

16:00 EST

High2.93	Low2.70	Vol126.27K
Open2.79	D1 Closing2.79	Amplitude8.23%
Mkt Cap75.46M	Tradable Cap54.73M	Total Shares26.67M
T/O356.04K	T/O Rate0.65%	Tradable Shares19.34M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"BEAT","market":"US","secType":"STK","nameCN":"Heartbeam Inc","latestPrice":2.83,"timestamp":1732568400000,"preClose":2.79,"halted":0,"volume":126272,"hourTrading":{"tag":"盘后","latestPrice":2.83,"preClose":2.83,"latestTime":"16:00 EST","volume":239,"amount":676.37,"timestamp":1732568404040},"delay":0,"floatShares":19340412,"shares":26665470,"eps":-0.692432,"marketStatus":"Not Yet Opened","change":0.04,"latestTime":"11-25 16:00:00 EST","open":2.79,"high":2.93,"low":2.7005,"amount":356042.732925,"amplitude":0.082258,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.692432,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1732611600000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1636606800000,"exchange":"NASDAQ","adjPreClose":2.79,"preHourTrading":{"tag":"盘前","latestPrice":2.8,"preClose":2.79,"latestTime":"08:13 EST","volume":830,"amount":2325.499976,"timestamp":1732540384584},"postHourTrading":{"tag":"盘后","latestPrice":2.83,"preClose":2.83,"latestTime":"16:00 EST","volume":239,"amount":676.37,"timestamp":1732568404040},"volumeRatio":0.710222,"impliedVol":0.0501,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/BEAT","defaultTab":"news","newsList":[{"id":"2484942489","title":"HeartBeam rises on positive data from two studies on its vector-based technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2484942489","media":"seekingalpha","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484942489?lang=en_us&edition=fundamental","pubTime":"2024-11-19 21:58","pubTimestamp":1732024712,"startTime":"0","endTime":"0","summary":"BrianAJackson/iStock via Getty Images  HeartBeam (NASDAQ:BEAT) announced positive results from two studies evaluating HeartBeam’s vector-based technology. Shares of the company up about 8% premarket. ","market":"nz","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/628328284/image_628328284.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/628328284/image_628328284.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4306787-heartbeam-rises-on-positive-data-from-two-studies-on-its-vector-based-technology","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["BEAT","BK4082"],"gpt_icon":0},{"id":"2484294464","title":"HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2484294464","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484294464?lang=en_us&edition=fundamental","pubTime":"2024-11-19 21:31","pubTimestamp":1732023060,"startTime":"0","endTime":"0","summary":"The studies further strengthen HeartBeam’s body of clinical evidence for its portable, cable-free, credit card-sized device that is designed to be capable of synthesizing a 12-lead ECG. The first study is a pilot study demonstrating similar performance of HeartBeam’s vector-based ambulatory technology to standard 12-lead ECGs for arrhythmia detection. HeartBeam’s vector-based technology captures the heart’s electrical signals from three dimensions. The Company’s first application of its groundbreaking technology is a cable-free, credit card-sized device that is designed to be capable of synthesizing a 12-lead electrocardiogram . The small size makes it convenient for patients to always have the device with them, ready to record an ECG whenever they feel symptoms to minimize delays in care. The HeartBeam system is currently under review with the FDA.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/ONcQ5HEJD.y88WT9U0PoQA--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/36a9a887ec986127e9c72818b8318e28","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/ONcQ5HEJD.y88WT9U0PoQA--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/36a9a887ec986127e9c72818b8318e28"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heartbeam-announces-positive-data-two-133100792.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4174","BEAT","BEATW","BK4107","BK4082","ECG","BK4117","AFG","PAC","BK4129"],"gpt_icon":1},{"id":"2483308456","title":"Heartbeam Price Target Maintained With a $8.00/Share by Benchmark","url":"https://stock-news.laohu8.com/highlight/detail?id=2483308456","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483308456?lang=en_us&edition=fundamental","pubTime":"2024-11-15 23:21","pubTimestamp":1731684060,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BEAT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 15, 2024 10:21 ET (15:21 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BEAT"],"gpt_icon":0},{"id":"2482468091","title":"HeartBeam Inc (BEAT) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges and ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2482468091","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482468091?lang=en_us&edition=fundamental","pubTime":"2024-11-09 07:01","pubTimestamp":1731106878,"startTime":"0","endTime":"0","summary":"Net Loss: $4.979 million for the third quarter ending September 30, 2024.Net Cash Used in Operating Activities: $3.3 million, primarily allocated to R&D and clinical initiatives.Cash Balance: $5.8 million as of September 30, 2024.For the complete transcript of the earnings call, please refer to the full earnings call transcript.HeartBeam Inc  has developed a groundbreaking cable-free 12-lead ECG technology that can be used by patients anywhere, offering high-resolution data capture.The company is targeting large addressable markets worth over $100 billion annually in the US alone, with a strategy to disrupt traditional cardiac care.The cash balance as of September 30, 2024, was $5.8 million, indicating limited financial runway without additional funding.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heartbeam-inc-beat-q3-2024-230118805.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BEAT","BEATW"],"gpt_icon":0},{"id":"2482038453","title":"Heartbeam Inc reports results for the quarter  - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2482038453","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482038453?lang=en_us&edition=fundamental","pubTime":"2024-11-09 05:01","pubTimestamp":1731099714,"startTime":"0","endTime":"0","summary":"Heartbeam Inc reports results for the quarter  - Earnings SummaryHeartbeam Inc BEAT.OQ reported a quarterly adjusted loss of 19 cents per share for the quarter , lower than the same quarter last year,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL8N3MF3FZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BEAT"],"gpt_icon":0},{"id":"2481116411","title":"HeartBeam, Inc. Advances Cardiac Monitoring Solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2481116411","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481116411?lang=en_us&edition=fundamental","pubTime":"2024-11-08 14:17","pubTimestamp":1731046668,"startTime":"0","endTime":"0","summary":"Heartbeam, Inc. ( ($BEAT) ) has released its Q3 earnings. Here is a breakdown of the information Heartbeam, Inc. presented to its investors. HeartB...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/heartbeam-inc-advances-cardiac-monitoring-solutions?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/heartbeam-inc-advances-cardiac-monitoring-solutions?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BEAT"],"gpt_icon":0},{"id":"2481771150","title":"HeartBeam Q3 2024 GAAP EPS $(0.19) Misses $(0.17) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2481771150","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481771150?lang=en_us&edition=fundamental","pubTime":"2024-11-08 05:57","pubTimestamp":1731016651,"startTime":"0","endTime":"0","summary":"HeartBeam (NASDAQ:BEAT) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.17) by 11.76 percent.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41826866/heartbeam-q3-2024-gaap-eps-0-19-misses-0-17-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"HeartBeam Q3 2024 GAAP EPS $(0.19) Misses $(0.17) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BEAT"],"gpt_icon":0},{"id":"2481500981","title":"Heartbeam Inc: Proposed Deal for  Tim Cruickshank Appointed as CFO & Branislav Vajdic Appointed as President","url":"https://stock-news.laohu8.com/highlight/detail?id=2481500981","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481500981?lang=en_us&edition=fundamental","pubTime":"2024-11-08 05:05","pubTimestamp":1731013505,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nTUA9W2LXN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BEAT"],"gpt_icon":0},{"id":"2481519332","title":"HeartBeam Reports Third Quarter 2024 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2481519332","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481519332?lang=en_us&edition=fundamental","pubTime":"2024-11-08 05:05","pubTimestamp":1731013500,"startTime":"0","endTime":"0","summary":"Continued Clinical and Regulatory Progress on the HeartBeam System. Key Appointments to Management Team Completed as Part of Planned Evolution in Preparation for US Commercialization. Strengthening Clinical Evidence Base, with Two Additional Studies to be Presented at the American Heart Association Conference in November 2024. Management to Host Webcast and Conference Call Today at 4:30 p.m. ET. SANTA CLARA, Calif., November 07, 2024----HeartBeam, Inc. , a medical technology company focused on transforming cardiac care through the power of personalized insights, has reported its financial and operational results for the third quarter ended September 30, 2024.The Company continues to make steady progress toward key clinical and regulatory milestones on the HeartBeam system.The 510 submission for the HeartBeam system continues to progress through active review by the FDA.HeartBeam continues to be confident in FDA clearance as the Company works interactively through the process.Upon the i","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/G0tS_FKpF.7kctmz7wIqMA--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/0fb4cd26face8875bb44e576bd1a3760","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/G0tS_FKpF.7kctmz7wIqMA--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/0fb4cd26face8875bb44e576bd1a3760"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heartbeam-reports-third-quarter-2024-210500505.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BEAT","BK4082","WRD","BEATW"],"gpt_icon":0},{"id":"2481161438","title":"Heartbeam Inc    expected to post a loss of 17 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2481161438","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481161438?lang=en_us&edition=fundamental","pubTime":"2024-11-06 12:52","pubTimestamp":1730868771,"startTime":"0","endTime":"0","summary":"* Heartbeam Inc     is expected to show no change in quarterly revenue when it reports  results on November 7 for the period ending September 30 2024   *    * LSEG's mean analyst estimate for Heartbea","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Heartbeam Inc    expected to post a loss of 17 cents a share - Earnings Preview","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BEAT"],"gpt_icon":0},{"id":"2480913793","title":"The US$115 billion question: Will Meta and Microsoft's huge spending on AI be worth it?","url":"https://stock-news.laohu8.com/highlight/detail?id=2480913793","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480913793?lang=en_us&edition=fundamental","pubTime":"2024-11-04 04:00","pubTimestamp":1730664019,"startTime":"0","endTime":"0","summary":"Many investors believe that artificial intelligence  will improve the world. But bullish or not, there is one question that AI aficionados cannot afford to ignore: how much will it cost?This week, that cost question was front and centre for the major US tech earnings results.Alphabet , the parent company of Google, has already flagged that its AI expenditure costs will remain elevated. Although it reported a 35% increase in cloud revenues last quarter, CAPEX  rose by more than 60%, to over US$13 billion. CEO Sundar Pichai has already flagged that this figure will likely be similar for Q4.But unlike Alphabet, two other Magnificent Seven names have increased their CAPEX forecasts for fiscal 2025. At a time when margins are being watched more closely than ever, any significant increase in costs will likely weigh on investor sentiment. And as anyone who's closely watched markets over the last few years could tell you, one miss in an otherwise perfect set of numbers can still cost a company","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/the-us-115-billion-question-will-meta-and-microsoft-s-huge-spending-on-ai-be-worth-it","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/the-us-115-billion-question-will-meta-and-microsoft-s-huge-spending-on-ai-be-worth-it","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["BK4535","IE00B19Z3581.USD","IE00BSNM7G36.USD","LU0096362180.USD","BK4533","LU0061474705.USD","IE00B3SWFQ91.USD","LU0234572021.USD","LU0149725797.USD","IE00B4JS1V06.HKD","IE00BQXX3C00.GBP","GOOGL","LU0211328371.USD","LU0127658192.USD","BK4585","BEAT","GB00B4QBRK32.GBP","IE00BQXX3F31.USD","IE00BN29S564.USD","LU0128525929.USD","IE00B19Z8X17.USD","IE0005OL40V9.USD","LU0433182093.SGD","LU0203202063.USD","IE00BJLML261.HKD","IE00B19Z8W00.USD","LU0053666078.USD","GOOG","LU0187121727.USD","IE00B19Z9505.USD","BK4577","IE000W1ABFV2.USD","GB00BDT5M118.USD","LU0061474960.USD","META","BK4082","LU0170899867.USD","IE00BWXC8680.SGD","LU0080751232.USD","LU0308772762.SGD","BK4550","BK4566","IE00BMPRXQ63.HKD","LU0724617625.USD","IE00BKPKM429.USD","LU0096364046.USD","BK4503","MSFT","LU0198837287.USD"],"gpt_icon":1},{"id":"2479635089","title":"Press Release: HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time","url":"https://stock-news.laohu8.com/highlight/detail?id=2479635089","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479635089?lang=en_us&edition=fundamental","pubTime":"2024-10-31 20:35","pubTimestamp":1730378100,"startTime":"0","endTime":"0","summary":"HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time. HeartBeam, Inc. , a medical technology company focused on transforming cardiac care by providing powerful cardiac insights wherever the patient is, will hold a conference call on Thursday, November 7, 2024 at 4:30 p.m. Eastern time to discuss its results for the third quarter ended September 30, 2024, and will be providing regulatory updates, reviewing ongoing initiatives, and anticipated milestones. A press release detailing these results will be issued prior to the call.HeartBeam CEO Robert Eno, Founder and President Branislav Vajdic, PhD, and CFO Timothy Cruickshank will host the conference call, followed by a question-and-answer period. The conference call will be accompanied by a presentation, which can be viewed during the webcast or accessed via the investor relations section of the Company's website here.To access the call, please use the following information:.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BEAT","BK4181","BK4588","HST","BK4082","BK4585","EML","BK4218","BK4161"],"gpt_icon":1},{"id":"2478919277","title":"HeartBeam, Inc. (BEAT): A Bull Case Theory","url":"https://stock-news.laohu8.com/highlight/detail?id=2478919277","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478919277?lang=en_us&edition=fundamental","pubTime":"2024-10-26 11:35","pubTimestamp":1729913719,"startTime":"0","endTime":"0","summary":"We came across abullish thesison HeartBeam, Inc.  on Triple S Special Situations Investing’s Substack by TripleS Special Situations. In this article, we will summarize the bulls’ thesis on BEAT. HeartBeam, Inc.'s share was trading at $2.30 as of Oct 24th.HeartBeam, Inc. is also not on our list of the31 Most Popular Stocks Among Hedge Funds. As per our database, 1 hedge fund portfolios held BEAT at the end of the second quarter which was 2 in the previous quarter. While we acknowledge the risk and potential of BEAT as an investment","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/1.HkZgcyyjA_sCaiKzQSeg--~B/aD0xMTQ0O3c9MTY0MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/e408f533010fd6ac3f9a6bfa35529acc","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/1.HkZgcyyjA_sCaiKzQSeg--~B/aD0xMTQ0O3c9MTY0MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/e408f533010fd6ac3f9a6bfa35529acc"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heartbeam-inc-beat-bull-case-033519582.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BEAT","BK4082","BEATW"],"gpt_icon":0},{"id":"2477638196","title":"HeartBeam Named \"Rising Star\" at the 6th Annual Digital Health Hub Foundation Awards","url":"https://stock-news.laohu8.com/highlight/detail?id=2477638196","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477638196?lang=en_us&edition=fundamental","pubTime":"2024-10-24 20:31","pubTimestamp":1729773060,"startTime":"0","endTime":"0","summary":"Company Receives Top Honors in the ‘Home Health Diagnostic’ Category for its Groundbreaking Technology that Captures the Heart’s Electrical Signals from Three Dimensions. SANTA CLARA, Calif., October 24, 2024----HeartBeam, Inc. , a medical technology company focused on transforming cardiac care by providing powerful cardiac insights wherever the patient is, announced today its selection as a winner of the 2024 Digital Health Hub Awards, hosted by The Digital Health Hub Foundation. Chief Executive Officer Rob Eno accepted the Rising Star award in the ‘Home Health Diagnostic’ category during the renowned HLTH global healthcare conference.The recognition highlights HeartBeam’s use of cutting-edge digital innovations to achieve its mission of unlocking a more personalized approach to cardiac care. HeartBeam’s groundbreaking vector-based technology captures the heart’s electrical signals from three dimensions to provide total heart intelligence. By leveraging AI to analyze the data-rich sig","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/rSo9M5SUlb8jmawU_odYkA--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/817dd808c77df282eba9ffac01d424ae","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/rSo9M5SUlb8jmawU_odYkA--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/817dd808c77df282eba9ffac01d424ae"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heartbeam-named-rising-star-6th-123100355.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","WRD","BEATW","IE00B66KJ199.SGD","IE00B7SZL793.SGD","BEAT","HUBG","IE0031619046.USD","IE00B19Z4B17.USD","BK4131"],"gpt_icon":0},{"id":"2477304736","title":"HeartBeam Appoints Robert Eno as New CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2477304736","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477304736?lang=en_us&edition=fundamental","pubTime":"2024-10-23 18:29","pubTimestamp":1729679376,"startTime":"0","endTime":"0","summary":"HeartBeam ( ($BEAT) ) has provided an update. HeartBeam, Inc. has appointed Robert Eno as the new CEO, effective October 21, 2024, to lead the comp...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/heartbeam-appoints-robert-eno-as-new-ceo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/heartbeam-appoints-robert-eno-as-new-ceo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BEAT"],"gpt_icon":0},{"id":"2476481765","title":"HeartBeam Appoints Robert Eno as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2476481765","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476481765?lang=en_us&edition=fundamental","pubTime":"2024-10-18 02:23","pubTimestamp":1729189405,"startTime":"0","endTime":"0","summary":"HeartBeam  appointed Robert Eno as chief executive officer, effective Monday.He succeeds founder Branislav Vajdic, who will become president and focus on more innovations for vector-based technology for heart health, including AI applications, HeartBeam said Thursday in a statement.Eno, 57. will focus on go-to-market strategies as CEO. He joined as president in January 2023.HeartBeam shares fell 3.1% in recent trading Thursday.Price: 2.21, Change: -0.07, Percent Change: -3.07","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4082","BEAT"],"gpt_icon":0},{"id":"2476106856","title":"BUZZ-HeartBeam rises on new CEO appointment","url":"https://stock-news.laohu8.com/highlight/detail?id=2476106856","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476106856?lang=en_us&edition=fundamental","pubTime":"2024-10-17 23:57","pubTimestamp":1729180647,"startTime":"0","endTime":"0","summary":"** Shares of heart device maker HeartBeam    up 3.51% at $2.34    ** Co appoints Robert Eno as new CEO, replacing Branislav Vajdic as CEO   ** Eno joined Co as President in January 2023; Branislav Vajdic to move into role of President   ** Co continues to work towards FDA 510 clearance for its vector-based technology, which  captures the heart’s electrical signals from three dimensions   ** Including session's move, stocks down 0.43% YTD ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BEAT","BK4082"],"gpt_icon":0},{"id":"2476512448","title":"HeartBeam appoints Robert Eno as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2476512448","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476512448?lang=en_us&edition=fundamental","pubTime":"2024-10-17 20:46","pubTimestamp":1729169211,"startTime":"0","endTime":"0","summary":"HeartBeam , a medical technology company said on Thursday that Robert Eno has been appointed Chief Executive Officer , effective Monday, October 21, 2024.As part of the long-planned transition, Branislav Vajdic, Ph.D., Founder and current CEO, will move into the role of President.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4169353-heartbeam-appoints-robert-eno-as-ceo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["BK4082","BEAT"],"gpt_icon":0},{"id":"2476125462","title":"BRIEF-HeartBeam Inc - Branislav Vajdic To Move Into Role Of President","url":"https://stock-news.laohu8.com/highlight/detail?id=2476125462","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476125462?lang=en_us&edition=fundamental","pubTime":"2024-10-17 20:38","pubTimestamp":1729168683,"startTime":"0","endTime":"0","summary":"Oct 17 (Reuters) - Heartbeam Inc   :   * HEARTBEAM APPOINTS ROBERT ENO AS CHIEF EXECUTIVE OFFICER IN PREPARATION FOR US COMMERCIALIZATION   * HEARTBEAM INC - BRANISLAV VAJDIC TO MOVE INTO ROLE OF PRESIDENTSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BEAT"],"gpt_icon":0},{"id":"2476757123","title":"Heartbeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization","url":"https://stock-news.laohu8.com/highlight/detail?id=2476757123","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476757123?lang=en_us&edition=fundamental","pubTime":"2024-10-17 20:31","pubTimestamp":1729168260,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241017:nTUA1K8RRC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BEAT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://heartbeam.com","stockEarnings":[{"period":"1week","weight":0.1841},{"period":"1month","weight":0.1646},{"period":"3month","weight":0.2578},{"period":"6month","weight":-0.0308},{"period":"1year","weight":1.0655},{"period":"ytd","weight":0.2043}],"compareEarnings":[{"period":"1week","weight":0.0159},{"period":"1month","weight":0.0319},{"period":"3month","weight":0.0641},{"period":"6month","weight":0.1358},{"period":"1year","weight":0.3124},{"period":"ytd","weight":0.2571}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.235559},{"month":2,"riseRate":0,"avgChangeRate":-0.173835},{"month":3,"riseRate":0.666667,"avgChangeRate":0.070447},{"month":4,"riseRate":0,"avgChangeRate":-0.113146},{"month":5,"riseRate":1,"avgChangeRate":0.160434},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.053451},{"month":7,"riseRate":1,"avgChangeRate":0.123333},{"month":8,"riseRate":0,"avgChangeRate":-0.168105},{"month":9,"riseRate":0.666667,"avgChangeRate":0.687606},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.175435},{"month":11,"riseRate":1,"avgChangeRate":0.207019},{"month":12,"riseRate":0.666667,"avgChangeRate":0.208764}],"exchange":"NASDAQ","name":"Heartbeam Inc","nameEN":"Heartbeam Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Heartbeam Inc(BEAT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Heartbeam Inc(BEAT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Heartbeam Inc,BEAT,Heartbeam Inc股票,Heartbeam Inc股票老虎,Heartbeam Inc股票老虎国际,Heartbeam Inc行情,Heartbeam Inc股票行情,Heartbeam Inc股价,Heartbeam Inc股市,Heartbeam Inc股票价格,Heartbeam Inc股票交易,Heartbeam Inc股票购买,Heartbeam Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Heartbeam Inc(BEAT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Heartbeam Inc(BEAT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction